Skip Navigation



Journal of the National Cancer Institute Advance Access published online on September 23, 2008
JNCI Journal of the National Cancer Institute, doi:10.1093/jnci/djn371
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
100/19/1337-b    most recent
djn371v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Article in JNCI
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2008.

MEMO TO THE MEDIA

New Model Predicts Relapse in Early Breast Cancer Patients Following Endocrine Therapy

The first 10% of the full text of this article appears below.

Researchers have developed and validated a model that predicts relapse in women with stage 2 or 3 breast cancer who have been treated with endocrine therapy prior to surgical removal of the tumor, according to a study published online September 23 in the Journal of the National Cancer . . . [Full Text of this Article]

Contact:

Citation:


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Article in JNCI

Outcome Prediction for Estrogen Receptor–Positive Breast Cancer Based on Postneoadjuvant Endocrine Therapy Tumor Characteristics
Matthew J. Ellis, Yu Tao, Jingqin Luo, Roger A'Hern, Dean B. Evans, Ajay S. Bhatnagar, Hilary A. Chaudri Ross, Alexander von Kameke, William R. Miller, Ian Smith, Wolfgang Eiermann, and Mitch Dowsett
J Natl Cancer Inst 2008 100: 1380-1388. [Abstract] [Full Text] [PDF]